Patent · US Active

Papillomavirus chimeric protein and application thereof

US10882887B2 · kind B2 · utility

0Cited by

0References

12Claims

0Family size

Assignee

INSTITUTE OF BASIC MEDICAL SCIENCES CHINESE ACADEMY OF MEDICAL SCIENCES · CN

Inventors

Xuemei Xu · Beijing, CN
Xue Chen · Qingshanqiao, CN
Ting Zhang · Princeton Junction, US
Zhirong Wang · 南丰镇, CN
Hongyang Liu · Beijing, CN
Shuo Wang · Hohhot, CN
Meili Hu · Beijing, CN

Key dates

Filing date	Mar 2, 2017
Grant date	Jan 5, 2021
Priority date	—
Expiry date	Sep 11, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2710/20034
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided is a papillomavirus chimeric protein, the skeleton thereof being a papillomavirus L1 protein or a mutant thereof, at least one human papillomavirus 33-type L2 protein or mutant polypeptide thereof being embedded on the skeleton. The present papillomavirus chimeric protein can be used for preparing a vaccine for preventing papillomavirus infections and infection induced disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.